BY MARIA OUTZE NIELSEN
-
Compounders sue FDA after decision on Novo Nordisk drug
United States copycat drugmakers declare that Novo Nordisk’s smash hit drugs will certainly remain to remain in brief supply.
-
Novo Nordisk to increase number of female executives to achieve diversity goal
Particularly, Novo Nordisk requires to discover 24 women execs to sign up with the firm’s leading administration in order to reach its variety targets.
-
Large Danish companies look forward to working with the US’ new DHHS administration. “We share the same ambitions”
Robert F. Kennedy Jr. is a forthright vaccination doubter and currently comes to be United States Assistant of Wellness and Human Being Solutions. A number of Danish firms see a ch…
-
Genmab CEO voices concern in uncertain times: Increases need for external manufacturers
Genmab chief executive officer Jan van de Winkel remains to check out the opportunity of internal manufacturing in the future, however except several years.
-
Genmab CEO voices concern in uncertain times: Increases need for external manufacturers
Genmab CEO Jan van de Winkel continues to explore the possibility of in-house production in the future, but not for many years.
-
Genmab chief: Crucial J&J decision doesn’t change strategy
Johnson & Johnson’s destiny choice will certainly be revealed soon. At the same time, Genmab is getting ready for the future with enhanced financial investments in late-…
-
US senators criticize Hims & Hers superbowl ad, calling for FDA action
Hims & Hers is implicated of “deceptive people” by holding back product details in brand-new Super Dish commercial.
-
Unexpected announcements and big fluctuations in 2024: Professionals predict more cautious communication from Novo Nordisk
With the worldwide give attention to Novo Nordisk, the corporate faces a troublesome balancing act in relation to public bulletins, say specialists.
-
FDA staff layoffs will slow agency’s work, sources say
Feasible discharges at the FDA can cause a loss of institutional expertise and will certainly have substantial effects for the testimonial of brand-new medications, experts inform …
-
FDA halts trials of Amgen’s weight-loss candidate
The pharmaceutical firm is waiting for more dialog with the authorities and is functioning to resume the Stage 1 test with the weight-loss prospect.
